On March 19, 2018 Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, reported that Jennifer K. Simpson, Ph.D., MSN, CRNP, President and Chief Executive Officer of Delcath will present at the Oppenheimer 28th Annual Healthcare Conference on Wednesday March 21, 2018 at 3:55pm Eastern Time. Dr. Simpson will highlight the recent corporate developments and provide an overview of the Company (Press release, Delcath Systems, MAR 19, 2018, View Source;p=RssLanding&cat=news&id=2338779 [SID1234524886]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the presentation will be available at www.delcath.com/investors-events, and a replay will be available at the same address approximately one hour after the presentation for approximately 90 days.

The Oppenheimer 28th Annual Healthcare Conference is being held at the March 20-21, 2018 The Westin New York Grand Central Hotel from March 20-21, 2018.